|Articles|June 1, 2001
- Pharmaceutical Executive-06-01-2001
- Volume 0
- Issue 0
Emotion - The New Brand Integrator
Author(s)Gil Bashe
Driven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.
Advertisement
Articles in this issue
over 24 years ago
Industry Under Investigationover 24 years ago
For Love of the Gameover 24 years ago
Field of Dreamsover 24 years ago
Workshop: Access Optionsover 24 years ago
Emotion - The New Brand Integratorover 24 years ago
Rx-to-OTC: Unwanted Attentionover 24 years ago
Emotion - Biotech Renaissance Manover 24 years ago
Relocation: Coming to Americaover 24 years ago
Stocks: Catching the Market Bluesover 24 years ago
Gathering LightNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
